Patents : |  |
| US Patent No. | Title |
| 7344720 | Vaccine composition
|
| 7368527 | HADDE71 polypeptides
|
| 7368531 | Human secreted proteins
|
| 7371383 | Recombinant anti-interleukin-9 antibodies
|
| 7371388 | Treatment of Sjogren's syndrome by administration of TR18 polypeptides
|
| 7371822 | Human G-protein coupled receptor variant of HM74, HGPRBMY74
|
| 7375192 | Antibodies that specifically bind to chemokine beta-4
|
| 7378097 | Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant
|
| 7381747 | Alpha 2 delta ligands for post-traumatic stress disorder
|
| 7381800 | Antibodies to HBIMF63 polypeptide
|
| 7384626 | Functionalized dendritic polymers for the capture and neutralization of biological and chemical agents
|
| 7364729 | Method of inducing a CTL response
|
| 7361341 | Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
|
| 7358074 | Human phosphatase RET31, and variants thereof
|
| 7344740 | Methods and apparatus to prevent, treat, and cure the symptoms of nausea caused by chemotherapy treatments of human cancers
|
| 7344860 | Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v
|
| 7344882 | Polynucleotides encoding variants of the TRP channel family member, LTRPC3
|
| 7345040 | Reverse-turn mimetics and compositions and methods relating thereto
|
| 7345048 | Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors
|
| 7345148 | Human G-protein coupled receptor, HGPRBMY29sv1 polypeptides
|
| 7348003 | Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors
|
| 7348149 | Methods of diagnosing Parkinson's disease by measuring expression level of RNA encoding human protein HLLRCR-1
|
| 7354584 | Recombinant IL-9 antibodies
|
| 7354888 | Antibacterial composition and methods thereof comprising a ternary builder mixture
|
| 7387900 | Colloidal metal compositions and methods
|
| 7390494 | Circovirus sequences associated with piglet weight loss disease (PWD)
|
| 7425622 | Antibodies against C3a receptor
|
| 7425700 | Systems and methods for discovery and analysis of markers
|
| 7429646 | Antibodies to human tumor necrosis factor receptor-like 2
|
| 7435808 | Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2
|
| 7439333 | Vascular endothelial growth factor 2
|
| 7442532 | Essential fungal CaYLR100w polypeptides, and methods of use
|
| 7446176 | 12 human secreted proteins
|
| 7449324 | Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
|
| 7452538 | Death domain containing receptor 4 antibodies and methods
|
| 7455840 | Compositions and methods to reduce mutagenesis
|
| 7425444 | Circovirus sequences associated with piglet weight loss disease (PWD)
|
| 7424370 | Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
|
| 7420044 | Nucleic acid and protein homologs and uses thereof
|
| 7390637 | Keratinocyte derived interferon
|
| 7390787 | Compositions and methods for treating infections using analogues of indolicidin
|
| 7393934 | Human G-protein chemokine receptor (CCR5) HDGNR10
|
| 7396324 | Centrifugal separator with first and second control panels
|
| 7405075 | Circovirus sequences associated with piglet weight loss disease (PWD)
|
| 7405212 | Helix mimetics and composition and methods related thereto
|
| 7407803 | Circovirus sequences associated with piglet weight loss disease (PWD)
|
| 7407952 | Reverse-turn mimetics and compositions and methods related thereto
|
| 7411051 | Antibodies to HDPPA04 polypeptide
|
| 7417121 | Human G-protein coupled receptor, HGPRBMY39
|
| 7456256 | BGS 4
|
